Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
SUMMARY: The Women's Health Initiative (WHI) double-blind, placebo-controlled clinical trial randomly assigned 36,282 postmenopausal women in the U.S. to 1,000 mg elemental calcium carbonate plus 400 IU of vitamin D(3) daily or placebo, with average intervention period of 7.0 years. The trial was designed to test whether calcium plus vitamin D supplementation in a population in which the use of these supplements was widespread would reduce hip fracture, and secondarily, total fracture and colorectal cancer. INTRODUCTION: This study further examines the health benefits and risks of calcium and vitamin D supplementation using WHI data, with emphasis on fractures, cardiovascular disease, cancer, and total mortality. METHODS: WHI calcium and vitamin D randomized clinical trial (CT) data through the end of the intervention period were further analyzed with emphasis on treatment effects in relation to duration of supplementation, and these data were contrasted and combined with corresponding data from the WHI prospective observational study (OS). RESULTS: Among women not taking personal calcium or vitamin D supplements at baseline, the hazard ratio [HR] for hip fracture occurrence in the CT following 5 or more years of calcium and vitamin D supplementation versus placebo was 0.62 (95 % confidence interval (CI), 0.38-1.00). In combined analyses of CT and OS data, the corresponding HR was 0.65 (95 % CI, 0.44-0.98). Supplementation effects were not apparent on the risks of myocardial infarction, coronary heart disease, total heart disease, stroke, overall cardiovascular disease, colorectal cancer, or total mortality, while evidence for a reduction in breast cancer risk and total invasive cancer risk among calcium plus vitamin D users was only suggestive. CONCLUSION: Though based primarily on a subset analysis, long-term use of calcium and vitamin D appears to confer a reduction that may be substantial in the risk of hip fracture among postmenopausal women. Other health benefits and risks of supplementation at doses considered, including an elevation in urinary tract stone formation, appear to be modest and approximately balanced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intakes in excess of 1200 to 1500 mg/day may increase the risk of developing kidney stones, cardiovascular disease, and stroke.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Calcium plus Vitamin D Supplementation and the Risk of Fractures
Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055218 · Cited by 1,883
Self-citationMeasurement Characteristics of the Women’s Health Initiative Food Frequency Questionnaire
Patterson, R. E., Kristal, A. R., Tinker, L. F., Carter, R. A., Bolton, M. P., & Agurs-Collins, T. (1999) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00055-6 · Cited by 1,025
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Wactawski-Wende, J., Kotchen, J. M., Anderson, G. L., Assaf, A. R., Brunner, R. L., O'Sullivan, M. J., Margolis, K. L., Ockene, J. K., Phillips, L., Pottern, L., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055222 · Cited by 980 · cited 2×
“Additional analyses led to reports of no clear evidence of benefit or harm for colorectal cancer [2], breast cancer [3], or other invasive cancer [4], though the possibility of a breast cancer risk reduction among women using little or no personal calcium supplements was noted [3].”
BackgroundSelf-citationBolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Outcomes ascertainment and adjudication methods in the women's health initiative
Curb, J. D., Mctiernan, A., Heckbert, S. R., Kooperberg, C., Stanford, J., Nevitt, M., Johnson, K. C., Proulx-Burns, L., Pastore, L., Criqui, M., et al. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00048-6 · Cited by 698 · cited 1×
“Clinical outcomes were self-reported semiannually in the CT and annually in the OS [27].”
MethodCalcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
Self-citationLanger, R. D., White, E., Lewis, C. E., Kotchen, J. M., Hendrix, S. L., & Trevisan, M. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00047-4 · Cited by 630 · cited 1×
“Baseline characteristics have been presented [26].”
Intake of Potassium, Magnesium, Calcium, and Fiber and Risk of Stroke Among US Men
Ascherio, A., Rimm, E. B., Hernán, M. A., Giovannucci, E. L., Kawachi, I., Stampfer, M. J., & Willett, W. C. (1998) · Circulation · doi:10.1161/01.cir.98.12.1198 · Cited by 451
Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer
Chlebowski, R. T., Johnson, K. C., Kooperberg, C., Pettinger, M., Wactawski-Wende, J., Rohan, T., Rossouw, J., Lane, D., O’Sullivan, M. J., Yasmeen, S., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn360 · Cited by 427
Self-citation
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
“The scientific literature is highly controversial in this area [31–34].”
BackgroundThe clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“Increasing calcium intake beyond the recommended levels has not been shown to be useful and may be harmful (140-144).”
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., Lips, P., Munns, C. F., Lazaretti-Castro, M., Giustina, A., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00126 · Cited by 1,143
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Weaver, C. M., Alexander, D. D., Boushey, C. J., Dawson-Hughes, B., Lappe, J. M., LeBoff, M. S., Liu, S., Looker, A. C., Wallace, T. C., & Wang, D. D. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3386-5 · Cited by 615
“[10] report hazard ratios and 95 % CIs for total and hip fracture for all trial participants with and without personal supplement use (see Table 2 in Prentice et al.”
BackgroundMethodInfluentialDietary Supplements: Regulatory Challenges and Research Resources
Dwyer, J., Coates, P., & Smith, M. (2018) · Nutrients · doi:10.3390/nu10010041 · Cited by 494
“There is little evidence that usual doses and forms of these nutrients give rise to health problems [42].”
BackgroundCamacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.gl · Cited by 478
(2021) · Menopause · doi:10.1097/gme.0000000000001831 · Cited by 461
“In the group that took an additional 1,000 mg of a calcium supplement daily, the risk of kidney stones was increased by 17%.77 The possibility that a calcium supplement of 1,000 mg daily (with total daily intake approximately 2,000 mg) is associated with increased cardiovascular risk was raised in a clinical trial and…”
ResultFortmann, S. P., Burda, B. U., Senger, C. A., Lin, J. S., & Whitlock, E. P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00729 · Cited by 442
“Indeed, the WHI investigators found no evidence of harm for CVD or cancer in their own reanalysis of their trial results, even when results were stratified by baseline supplement use and the results of their large observational study were added (78).”
BackgroundCalcium intake and risk of fracture: Systematic review
Bolland, M. J., Leung, W., Tai, V., Bastin, S., Gamble, G. D., Grey, A., & Reid, I. R. (2015) · BMJ · doi:10.1136/bmj.h4580 · Cited by 351
Dietary reference values for vitamin D
EFSA Panel on Dietetic Products, N. A. A. (. (2016) · EFSA Journal · doi:10.2903/j.efsa.2016.4547 · Cited by 304
Morin, S. N., Leslie, W. D., & Schousboe, J. T. (2025) · JAMA · doi:10.1001/jama.2025.6003 · Cited by 220
Calcium deficiency worldwide: prevalence of inadequate intakes and associated health outcomes
Shlisky, J., Mandlik, R., Askari, S., Abrams, S., Belizan, J. M., Bourassa, M. W., Cormick, G., Driller‐Colangelo, A., Gomes, F., Khadilkar, A., et al. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14758 · Cited by 233
Dietary reference values for vitamin K
EFSA Panel on Dietetic Products, N. A. A. (., Turck, D., Bresson, J., Burlingame, B., Dean, T., Fairweather‐Tait, S., Heinonen, M., Hirsch‐Ernst, K. I., Mangelsdorf, I., McArdle, H. J., et al. (2017) · EFSA Journal · doi:10.2903/j.efsa.2017.4780 · Cited by 218
Kahwati, L. C., Weber, R. P., Pan, H., Gourlay, M., LeBlanc, E., Coker-Schwimmer, M., & Viswanathan, M. (2018) · JAMA · doi:10.1001/jama.2017.21640 · Cited by 220
Self-citationHarvey, N. C., Biver, E., Kaufman, J.-M., Bauer, J., Branco, J., Brandi, M. L., Bruyère, O., Coxam, V., Cruz-Jentoft, A., Czerwinski, E., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3773-6 · Cited by 193
“The WHI investigators also examined the risk of renal stones, stratified by use of personal supplements and adherence to study medication [22].”
InfluentialCalcium Intake and Cardiovascular Disease Risk: An Updated Systematic Review and Meta-analysis
Chung, M., Tang, A. M., Fu, Z., Wang, D. D., & Newberry, S. J. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1165 · Cited by 166
Schwingshackl, L., Boeing, H., Stelmach-Mardas, M., Gottschald, M., Dietrich, S., Hoffmann, G., & Chaimani, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013516 · Cited by 165
“Although it seems that vitamin E has some beneficial effects on cardiovascular outcomes, a meta-analysis of clinical trials reported a significant increased risk of total mortality, including mainly secondary prevention trials for high-dose vitamin E ($400 IU/d) (101).”
Lewis, J. R., Radavelli-Bagatini, S., Rejnmark, L., Chen, J. S., Simpson, J. M., Lappe, J. M., Mosekilde, L., Prentice, R. L., & Prince, R. L. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2311 · Cited by 164
“Two large studies have identified reduced risk of CVD in participants using calcium supplements,((28,35)) whereas calcium supplementation has also been associated with a reduced risk of all‐cause mortality in women.”
BackgroundMethodSelf-citationDiabetes, Diabetic Complications, and Fracture Risk
Oei, L., Rivadeneira, F., Zillikens, M. C., & Oei, E. H. G. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0260-5 · Cited by 125
Mechanistic Effects of Calcitriol in Cancer Biology
Díaz, L., Díaz‐Muñoz, M., García-Gaytán, A. C., & Méndez, I. G. (2015) · Nutrients · doi:10.3390/nu7065020 · Cited by 143
“Also, in a study that examined calcium plus vitamin D supplementation on breast cancer suggested a decrease in breast cancer risk [49].”
BackgroundOptimising health after early menopause
Mishra, G. D., Davies, M. C., Hillman, S., Chung, H., Roy, S., Maclaran, K., & Hickey, M. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02800-3 · Cited by 149
Cauley, J. A., Chlebowski, R. T., Wactawski-Wende, J., Robbins, J. A., Rodabough, R. J., Chen, Z., Johnson, K. C., O'Sullivan, M. J., Jackson, R. D., & Manson, J. E. (2013) · Journal of Women's Health · doi:10.1089/jwh.2013.4270 · Cited by 120
“incidence with longer term use.(19) Clinical vertebral fracture risk, a post hoc outcome was lower postintervention and during the cumulative follow-up period among women randomized to supplements: There would be four fewer vertebral fractures in 10,000 women taking supplements for 1 year.”
BackgroundSelf-citationBertoldo, F., Cianferotti, L., Monaco, M. D., Falchetti, A., Fassio, A., Gatti, D., Gennari, L., Giannini, S., Girasole, G., Gonnelli, S., et al. (2022) · Nutrients · doi:10.3390/nu14194148 · Cited by 125
“In that study, patients had unlimited access to alimentary calcium [128].”
BackgroundMethodZhu, K., & Prince, R. L. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0248-6 · Cited by 106
Postmenopausal osteoporosis: Assessment and management
Rizzoli, R. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.09.005 · Cited by 139
Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond
O’Connor, D. L., Blake, J. M., Bell, R. C., Bowen, A., Callum, J., Fenton, S., Gray‐Donald, K., Rossiter, M. D., Adamo, K. B., Brett, K., et al. (2016) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2016.01.001 · Cited by 120
Calcium supplementation in osteoporosis: useful or harmful?
Chiodini, I., & Bolland, M. J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0113 · Cited by 110
Yang, B., McCullough, M. L., Gapstur, S. M., Jacobs, E. J., Bostick, R. M., Fedirko, V., Flanders, W. D., & Campbell, P. T. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3024 · Cited by 100
Yakoob, M. Y., Shi, P., Hu, F. B., Campos, H., Rexrode, K. M., Orav, E. J., Willett, W. C., & Mozaffarian, D. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.083097 · Cited by 92
“The absence of effects on stroke of supplementation with other dairy components such as calcium or vitamin D (49, 50), as well as small effects of these components on blood pressure (51), is consistent with our findings.”
ResultDiab, D. L., & Watts, N. B. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000436194.10599.94 · Cited by 85
Khaw, K., Luben, R., & Wareham, N. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086413 · Cited by 98
“Many trials have focused on high-risk groups such as trials of the prevention of fractures in the very old or individuals with osteoporosis, and the largest trial to date, the Women’s Health Initiative, was conducted only in postmenopausal women (33).”
BackgroundChakhtoura, M., Bacha, D. S., Gharios, C., Ajjour, S., Assaad, M. A., Jabbour, Y., Kahale, F., Bassatne, A., Antoun, S., Akl, E. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab742 · Cited by 99
“0 6) Prentice(50) Beyond NA NA NA NA post-hoc NA NA 14.”
BackgroundInfluentialCholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
Henríquez, M. S., & Romero, M. J. G. D. T. (2020) · Nutrients · doi:10.3390/nu12061617 · Cited by 107
“in 2013, in which a 35% significant reduction in the relative risk of hip fracture was observed in patients randomized to treatment with cholecalciferol and calcium, with this risk reduction increased to 76% in those patients who were considered sufficiently adherent to exogenous supplementation with cholecalciferol a…”
BackgroundCalcium supplementation and cardiovascular risk: A rising concern
Tankeu, A. T., Agbor, V. N., & Noubiap, J. J. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13010 · Cited by 85
Gholami, F., Moradi, G., Zarei, B., Rasouli, M. A., Nikkhoo, B., Roshani, D., & Ghaderi, E. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1236-7 · Cited by 91
Romagnoli, E., Pepe, J., Piemonte, S., Cipriani, C., & Minisola, S. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0435 · Cited by 89
Yang, C., Shi, X., Xia, H., Yang, X., Liu, H., Pan, D., & Sun, G. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1649219 · Cited by 76
Budhathoki, S., Hidaka, A., Yamaji, T., Sawada, N., Tanaka‐Mizuno, S., Kuchiba, A., Charvat, H., Goto, A., Kojima, S., Sudo, N., et al. (2018) · BMJ · doi:10.1136/bmj.k671 · Cited by 75
Kong, S. H., Jang, H. N., Kim, J. H., Kim, S. W., & Shin, C. S. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1374 · Cited by 86
“The complete list and characteristics of the included studies are listed in Table 1 [7,10,18-47].”
BackgroundInfluentialA Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D
Shah, V. P., Nayfeh, T., Alsawaf, Y., Saadi, S. M., Farah, M. H., Zhu, Y., Firwana, M., Seisa, M. O., Wang, Z., Scragg, R. K. R., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae312 · Cited by 98
Weinstein, S. J., Purdue, M. P., Smith‐Warner, S. A., Mondul, A. M., Black, A., Ahn, J., Huang, W., Horst, R. L., Kopp, W., Rager, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29157 · Cited by 70
“13 for the calcium plus vitamin D arm) among the 15,302 women who did not self-supplement.(41) A smaller trial that used 1,100 IU vitamin D combined with 1.”
BackgroundMorgen, E. K., & Naugler, C. T. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpyxdaus2f8xjy · Cited by 79
Fischer, V., Haffner‐Luntzer, M., Prystaz, K., Scheidt, A. V., Busse, B., Schinke, T., Amling, M., & Ignatius, A. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-07511-2 · Cited by 71
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
Fuggle, N. R., Cooper, C. C., Harvey, N. C., Al‐Daghri, N. M., Brandi, M. L., Bruyère, O., Cano, A., Dennison, E. M., Díez‐Pérez, A., Kaufman, J., et al. (2020) · Drugs · doi:10.1007/s40265-020-01364-2 · Cited by 79
Calcium supplement intake and risk of cardiovascular disease in women
Paik, J. M., Curhan, G. C., Sun, Q., Rexrode, K. M., Manson, J. E., Rimm, E. B., & Taylor, E. N. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2732-3 · Cited by 65
“[33] did not find an association with CVD among women taking calcium supplements alone (OS) or calcium in combination with vitamin D (RCT, OS, and combined RCT and OS analysis).”
BackgroundSelf-citationCalcium supplements and cardiovascular risk: 5 years on
Bolland, M. J., Grey, A. B., & Reid, I. R. (2013) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098613499790 · Cited by 72
“Recently the WHI investigators have reanalyzed their data using the same approach, obtaining similar results [Prentice et al. 2013].”
BackgroundResultPaschalis, E. P., Gamsjaeger, S., Hassler, N., Fahrleitner‐Pammer, A., Dobnig, H., Stepan, J. J., Pavo, I. J., Eriksen, E. F., & Klaushofer, K. (2016) · Bone · doi:10.1016/j.bone.2016.11.002 · Cited by 69
Huang, D., Lei, S., Wu, Y., Weng, M., Zhou, Y., Xu, J., Xia, D., Xu, E., Lai, M., & Zhang, H. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.012 · Cited by 60
Langsetmo, L., Berger, C., Kreiger, N., Kovács, C. S., Hanley, D. A., Jamal, S. A., Whiting, S. J., Genest, J. J., Morin, S. N., Hodsman, A. B., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1516 · Cited by 62
Jemielita, T., Leonard, M. B., Baker, J. F., Sayed, S. U., Zemel, B. S., Justine Shults, A., Herskovitz, R. M., & Denburg, M. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3296-6 · Cited by 59
RETIRED: Osteoporosis in Menopause
Khan, A. A., Fortier, M. P., Fortier, M. P., Reid, R. L., Abramson, B. L., Blake, J. M., Desindes, S., Dodin, S., Graves, L. E., Guthrie, B., et al. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30489-8 · Cited by 68
RetractedGanmaa, D., Enkhmaa, D., Erdenebileg, N., Sukhbaatar, S., Tumur‐Ochir, K., & Manson, J. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13399 · Cited by 67
Self-citationVitamin D activities and metabolic bone disease
Ryan, J. W., Anderson, P., Turner, A. G., & Morris, H. A. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.024 · Cited by 52
LeBoff, M. S., Yue, A. Y., Copeland, T., Cook, N. R., Buring, J. E., & Manson, J. E. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.007 · Cited by 50
“Although some observational studies and randomized controlled trials (RCTs) show that supplemental vitamin D protects against fractures and has beneficial effects on bone health measures [14–17] (Fig.”
BackgroundSelf-citationCost-benefit analysis of calcium and vitamin D supplements
Weaver, C. M., Bischoff-Ferrari, H. A., & Shanahan, C. J. (2019) · Archives of Osteoporosis · doi:10.1007/s11657-019-0589-y · Cited by 55
Pana, T. A., Dehghani, M., Baradaran, H. R., Neal, S. R., Wood, A. D., Kwok, C. S., Loke, Y. K., Luben, R., Mamas, M. A., Khaw, K., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00710-8 · Cited by 53
Asemi, Z., Saneei, P., Sabihi, S.-S., Feizi, A., & Esmaillzadeh, A. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.03.008 · Cited by 55
A systematic review and meta-analysis of vitamin D and calcium in preventing osteoporotic fractures
Eleni, A., & Petrou, P. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05122-3 · Cited by 62
“2013 [17] Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study Osteoporosis International”
BackgroundMethodResultInfluentialLópez-Caleya, J. F., Ortega-Valín, L., Fernández‐Villa, T., Delgado‐Rodríguez, M., Martín, V., & Molina, A. J. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01512-3 · Cited by 48
A Review of Nutritional Requirements of Adults Aged ≥65 Years in the UK
Dorrington, N., Fallaize, R., Hobbs, D. A., Weech, M., & Lovegrove, J. A. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa153 · Cited by 60
Bhojani, N., Bjazevic, J., Wallace, B., Lee, L., Kaler, K. S., Dion, M., Cowan, A., Sultan, N., Chew, B. H., & RAZVI, H. A. (2022) · Canadian Urological Association Journal · doi:10.5489/cuaj.7872 · Cited by 63
Weaver, C. M. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0208-1 · Cited by 58
Management of beta‐thalassemia–associated osteoporosis
Giusti, A., Pinto, V. M., Forni, G. L., & Pilotto, A. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13041 · Cited by 47
Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing
Kushchayeva, Y. S., Pestun, I., Kushchayev, S. V., Radzikhovska, N., & Lewiecki, E. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247477 · Cited by 54
Yang, B., Campbell, P. T., Gapstur, S. M., Jacobs, E. J., Bostick, R. M., Fedirko, V., Flanders, W. D., & McCullough, M. L. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.117994 · Cited by 53
Micronutrient Intake in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity
J. Kelly, O., C. Gilman, J., Kim, Y., & Z. Ilich, J. (2016) · Current Aging Science · doi:10.2174/1874609809666160509122001 · Cited by 42
Strontium ranelate: in search for the mechanism of action
Stepan, J. J. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0494-1 · Cited by 42
“Although it is known that long-term treatment with calcium and vitamin D significantly reduces the risk of hip fractures, [53], none of the studies published to date has compared the efficacy of calcium administration during the day and as late as at bedtime.”
BackgroundKelly, O. J., Gilman, J. C., & Ilich, J. Z. (2018) · Nutrients · doi:10.3390/nu10010107 · Cited by 53
“An incorrect ratio of mineral intakes may explain why CVD risk is associated with Ca supplement use [39,40]; here the much higher intake of Ca may be affecting the ratios of the other minerals and possibly their physiological actions.”
BackgroundVitamin D regulation of energy metabolism in cancer
Sheeley, M. P., Andolino, C. J., Kiesel, V. A., & Teegarden, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15424 · Cited by 45
Lewis, J. R., Zhu, K., Thompson, P. L., & Prince, R. L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2117 · Cited by 43
Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say?
Curtis, E., Cooper, C. C., & Harvey, N. C. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01799-x · Cited by 45
“The WHI investigators also examined the risk of renal stones, stratified by use of personal calcium and vitamin D supplements at baseline and adherence to study medication [30].”
BackgroundRuxton, C. H. S., Derbyshire, E. J., & Toribio-Mateas, M. A. (2015) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12335 · Cited by 48
“(72) reported that 1000 mg of calcium plus 10 lg (400 IU) vitamin D3 was associated with a reduced risk of hip fracture among postmenopausal women.”
BackgroundMartin, B. R., McCabe, G. P., McCabe, L. D., Jackson, G. S., Horcajada, M. N., Offord‐Cavin, E., Peacock, M., & Weaver, C. M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3767 · Cited by 42
Shirazi, L. G., Almquist, M., Borgquist, S., Malm, J., & Manjer, J. (2016) · The Breast · doi:10.1016/j.breast.2016.06.002 · Cited by 47
“Among randomized clinical trials, two showed no association between 25OHD3 and breast cancer risk [24,25] and one showed aweakly reduced breast cancer risk among women on vitamin D supplements [26].”
BackgroundManoj, P., Derwin, R., & George, S. (2022) · International Journal of Older People Nursing · doi:10.1111/opn.12492 · Cited by 51
Vitamin D in the cancer patient
Kennel, K. A., & Drake, M. T. (2013) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283640f74 · Cited by 43
“A recent subset analysis of the Women’s Health Initiative (WHI) study, in which 36 282 postmenopausal women in the USA were randomly assigned to receive either daily 1000 mg elemental calcium carbonate and 400 IU of vitamin D3 or placebo, was only suggestive of a decrease in breast cancer risk in the treated patients…”
MethodWu, Y., Huang, R., Wang, M., Bernstein, L., Bethea, T. N., Chen, C., Chen, Y., Eliassen, A. H., Freedman, N. D., Gaudet, M. M., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab097 · Cited by 45
Bone and heart health in menopause
Nash, Z., Wattar, B. H. A., & Davies, M. C. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2022.03.002 · Cited by 46
Cheng, S., Chu, W., Chou, W.-H., Chu, W., & Kang, Y. (2024) · Drug Safety · doi:10.1007/s40264-024-01475-9 · Cited by 36
“However, a daily intake of 1000 mg of calcium has been shown to reduce fracture risk without increasing the risk of cardiovascular events [61].”
Zhou, W. Z., Langsetmo, L., Berger, C., Poliquin, S., Kreiger, N., Barr, S. I., Kaiser, S., Josse, R. G., Prior, J. C., Towheed, T., et al. (2013) · PubMed · Cited by 34
Vitamin D and cardiovascular disease
Apostolakis, M., Armeni, E., Bakas, P., & Lambrinoudaki, I. V. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.05.010 · Cited by 43
Vitamin D and Cardiovascular Disease: An Appraisal of the Evidence
Schnatz, P. F., & Manson, J. E. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.211037 · Cited by 34
Self-citationHarvey, N. C., D’Angelo, S., Paccou, J., Curtis, E. M., Edwards, M. H., Raisi‐Estabragh, Z., Walker-Bone, K. E., Petersen, S. E., & Cooper, C. C. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3375 · Cited by 33
“Indeed, analysis of the WHI by its own investigators, accounting for personal calcium/vitamin D supplementation as did the New Zealand group, did not demonstrate adverse cardiovascular effects.((11)) Consistent with this finding, in the present analysis, we did not observe any interaction between calcium/vitamin D”
ResultInfluentialChakhtoura, M., Chamoun, N., Rahme, M., & Fuleihan, G. E. (2019) · Bone · doi:10.1016/j.bone.2019.115112 · Cited by 40
Mattioli, A. V., Coppi, F., Severino, P., Penna, C. R. R., Pagliaro, P., Dei, A., Bucciarelli, V., Madonna, R., Tarperi, C., Schena, F. F., et al. (2024) · Nutrients · doi:10.3390/nu17010115 · Cited by 38
“…randomized to receive calcium (1000 mg/day) plus vitamin D3 (400 IU/day) or a placebo, no significant impact of combined calcium and vitamin D supplementation was shown on coronary or cerebrovascular events; although, the dose of vitamin D used was relatively low compared to other studies [63].”
Web of industry, advocacy, and academia in the management of osteoporosis
Grey, A. B., & Bolland, M. J. (2015) · BMJ · doi:10.1136/bmj.h3170 · Cited by 34
The Risks and Benefits of Calcium Supplementation
Shin, C. S., & Kim, K. M. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.1.27 · Cited by 36
An update on breast cancer chemotherapy-associated toxicity and their management approaches
Langeh, U., Kumar, V., Ahuja, P., Singh, C., & Singh, A. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100119 · Cited by 59
Calcium and Vitamin D Supplementation on Bone Health: Current Evidence and Recommendations
Chen, L.-R., Wen, Y.-T., Kuo, C.-L., & Chen, K.-H. (2014) · International journal of gerontology · doi:10.1016/j.ijge.2014.06.001 · Cited by 38
Calcium risk–benefit updated—New WHI analyses
Reid, I. R., & Bolland, M. J. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.10.003 · Cited by 31
Continued Interest and Controversy: Vitamin D in HIV
Hsieh, E., & Yin, M. T. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0401-4 · Cited by 32
Risk-reducing medications for primary breast cancer: a network meta-analysis
Mocellin, S., Goodwin, A., & Pasquali, S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012191.pub2 · Cited by 40
Diagnosis and Treatment of Osteoporosis in Older Adults
Diab, D. L., & Watts, N. B. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.007 · Cited by 32
Thomson, C. A., Aragaki, A. K., Prentice, R. L., Stefanick, M. L., Manson, J. E., Wactawski‐Wende, J., Watts, N. B., Horn, L. V., Shikany, J. M., Rohan, T. E., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2598 · Cited by 36
Self-citationSecondary Prevention After an Osteoporosis-Related Fracture
Sale, J. E. M., Beaton, D., & Bogoch, E. R. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.01.009 · Cited by 35
Zhou, X., Zheng, W., Gowda, G. A. N., Raftery, D., Donkin, S. S., Bequette, B. J., & Teegarden, D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.022 · Cited by 31
Bailey, R. L., Sahni, S., Chocano-Bedoya, P. O., Daly, R. M., Welch, A. A., Bischoff-Ferrari, H. A., & Weaver, C. M. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy111 · Cited by 30
“However, in re-analysis of the same data with the exclusion of those taking personal supplements and those who were noncompliant with the study supplements, there was a significant reduction (30%) in hip fracture among those randomly assigned to receive the study supplements (15).”
MethodChin, K., Appel, L. J., & Michos, E. D. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0637-2 · Cited by 28
Metadata
- Authors
- Prentice, R. L., Pettinger, M. B., Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Anderson, G. L., Chlebowski, R. T., Manson, J. E., Van Horn, L., Vitolins, M. Z., Datta, M., LeBlanc, E. S., Cauley, J. A., & Rossouw, J. E.
- Affiliations
- Fred Hutch Cancer Center (US)
- The Ohio State University (US)
- The Lundquist Institute (US)
- Brigham and Women's Hospital (US)
- Wake Forest University Health Sciences (US)
- Kaiser Permanente Center for Health Research (US)
- University of Pittsburgh (US)
- National Institutes of Health (US)
- Corresponding author
- Prentice, R. L.
- ORCID
- Venue
- Osteoporosis International
- Published
- 2012-12-04
- Volume
- 24
- Issue
- 2
- Pages
- 567-580
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- PMC
- PMC3557387
- OpenAlex
- W2009142498
- Cited by
- 295
- References
- 31
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 17 · 2023: 9 · 2022: 16 · 2021: 18 · 2020: 29 · 2019: 21 · 2018: 25 · 2017: 19 · 2016: 34 · 2015: 35 · 2014: 32 · 2013: 30
- FWCI
- 22.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Osteoporosis International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- National University of Singapore (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Health and Human Services (42129‐32, 42107-26, 32108‐9, 32118-32119, 32115, 32111‐13, 32100‐2, 44221, 32105‐6, 32122, 24152, N01-WH-2-2110)
- Brigham and Women's Hospital
- Ohio State University
- Wake Forest University
- University of Pittsburgh
- MedStar Health Research Institute
- National Institutes of Health (n01wh42124-20-0-0, n01wh42120-22-0-1, N01-WH-4-2107, n01wh42125-19-0-1, n01wh042116-008, n01wh32112-26-0-1, N01-WH-4-2122, N01-WH-3-2109, n01wh42130-23-0-1, n01wh42123-22-0-1, n01wh42108-21-0-1, N01-WH-3-2111, n01wh042114-008, n01wh32118-27-0-1, N01-WH-3-2119, 32122, n01wh42110-25-0-0, 32111‐13, n01wh42122-22-0-1, N01-WH-4-2126, 32108‐9, 42129‐32, N01-WH-4-2111, N01-WH-4-2129, n01wh42131-22-0-1, N01-WH-4-2130, n01wh44221-7-0-1, N01-WH-3-2118, 42107–26, n01wh42129-23-0-1, N01-WH-4-2116, N01-WH-4-2110, n01wh42115-19-0-1, n01wh32111-28-0-1, n01wh32115-26-0-1, N01 WH 44221, n01wh22110-38-0-0, N01-WH-3-2115, N01-WH-4-2117, 32118-32119, n01wh42132-22-0-1, 44221, n01wh42121-21-0-1, 32115, n01wh42111-19-0-1, 32100‐2, N01-WH-4-2124, n01wh42113-23-0-1, N01-WH-4-2131, n01wh32113-30-0-1, N01-WH-4-2113, n01wh42119-25-0-1, N01-WH-4-2109, N01-WH-4-2115, N01-WH-4-2132, N01-WH-3-2112, N01-WH-4-2121, n01wh42126-26-0-1, n01wh32122-31-0-1, n01wh42118-20-0-1, N01-WH-4-2119, n01wh32119-24-0-1, N01-WH-3-2122, n01wh42107-22-0-1, N01-WH-4-2125, n01wh42109-28-0-1, n01wh042112-013, N01-WH-4-2120, N01-WH-2-2110, N01-WH-4-2114, n01wh42117-21-0-1, N01-WH-4-2123, N01-WH-4-2118, 24152, N01-WH-4-2112, N01-WH-4-2108, N01 WH022110, CA53996, n01wh32109-27-0-1, N01-WH-3-2113, 32105-6)
- U.S. Public Health Service (32101, 32100, 24152, 32105, 32102, 32108)
- University at Buffalo
- National Heart, Lung, and Blood Institute (32100‐2, 32118‐32119, N01‐WH‐22110, N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 32118, 42107‐26, 32119, 24152, and 44221, 32105–6, 32108‐9, 32111–13, 32115, 42129‐32, 32122, 44221)
- National Cancer Institute (CA53996, R25CA122061, P01CA053996, R01CA119171)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- calcium supplementation, vitamin D supplementation, postmenopausal women, hip fracture, fracture risk, cardiovascular disease, colorectal cancer, breast cancer, all-cause mortality, urolithiasis, duration of supplementation, Women's Health Initiative
- MeSH terms
- Aged, Calcium Carbonate, Cardiovascular Diseases, Cholecalciferol, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Female, Hip Fractures, Humans, Middle Aged, Neoplasms, United States, Urinary Calculi, Osteoporosis, Postmenopausal, Risk Assessment, Dietary Supplements, Bone Density Conservation Agents, Osteoporotic Fractures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.